<DOC>
	<DOC>NCT00674453</DOC>
	<brief_summary>The objective of the study is to demonstrate the effects that lasofoxifene has on serum markers of bone metabolism.</brief_summary>
	<brief_title>The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis, Postmenopausal</mesh_term>
	<criteria>Postmenopausal women over 50 years who have low bone mineral density. Women who are under 50 years of age, are premenopausal, or who currently have osteoporosis are excluded.</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>lasofoxifene</keyword>
	<keyword>bone density</keyword>
	<keyword>bone markers</keyword>
</DOC>